These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1410 related articles for article (PubMed ID: 18242379)

  • 21. Comparative outcomes following endoscopic ureteral detachment and formal bladder cuff excision in open nephroureterectomy for upper urinary tract transitional cell carcinoma.
    Walton TJ; Sherwood BT; Parkinson RJ; Obakponovwe O; Thomas SA; Taylor MC; England RC; Lemberger RJ
    J Urol; 2009 Feb; 181(2):532-9. PubMed ID: 19084866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of diagnostic ureteroscopy on intravesical recurrence and survival in patients with urothelial carcinoma of the upper urinary tract.
    Ishikawa S; Abe T; Shinohara N; Harabayashi T; Sazawa A; Maruyama S; Kubota K; Matsuno Y; Osawa T; Shinno Y; Kumagai A; Togashi M; Matsuda H; Mori T; Nonomura K
    J Urol; 2010 Sep; 184(3):883-7. PubMed ID: 20643446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
    Thompson RH; Krambeck AE; Lohse CM; Elliott DS; Patterson DE; Blute ML
    Urology; 2008 Apr; 71(4):713-7. PubMed ID: 18267338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population.
    Tan LB; Chang LL; Cheng KI; Huang CH; Kwan AL
    BJU Int; 2009 Feb; 103(3):312-6. PubMed ID: 18782312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The oncological results of laparoscopic nephroureterectomy for upper urinary tract transitional cell cancer are equal to those of open nephroureterectomy.
    Waldert M; Remzi M; Klingler HC; Mueller L; Marberger M
    BJU Int; 2009 Jan; 103(1):66-70. PubMed ID: 18710438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tract.
    Thompson RH; Krambeck AE; Lohse CM; Elliott DS; Patterson DE; Blute ML
    BJU Int; 2008 Nov; 102(9):1107-10. PubMed ID: 18522631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk?
    Volkmer BG; Schnoeller T; Kuefer R; Gust K; Finter F; Hautmann RE
    J Urol; 2009 Dec; 182(6):2632-7. PubMed ID: 19836794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Kim KH; You D; Jeong IG; Hong JH; Ahn H; Kim CS
    Urol Oncol; 2013 Nov; 31(8):1643-9. PubMed ID: 22591745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival.
    Brausi MA; Gavioli M; De Luca G; Verrini G; Peracchia G; Simonini G; Viola M
    Eur Urol; 2007 Nov; 52(5):1414-8. PubMed ID: 17507148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.
    Li CC; Chang TH; Wu WJ; Ke HL; Huang SP; Tsai PC; Chang SJ; Shen JT; Chou YH; Huang CH
    Eur Urol; 2008 Nov; 54(5):1127-34. PubMed ID: 18243511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Independent predictors of contralateral metachronous upper urinary tract transitional cell carcinoma after nephroureterectomy: multi-institutional dataset from three European centers.
    Novara G; De Marco V; Dalpiaz O; Galfano A; Bouygues V; Gardiman M; Martignoni G; Patard JJ; Artibani W; Ficarra V
    Int J Urol; 2009 Feb; 16(2):187-91. PubMed ID: 19054165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
    Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
    Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elective management of transitional cell carcinoma of the distal ureter: can kidney-sparing surgery be advised?
    Giannarini G; Schumacher MC; Thalmann GN; Bitton A; Fleischmann A; Studer UE
    BJU Int; 2007 Aug; 100(2):264-8. PubMed ID: 17532855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma.
    Wu CF; Chang PL; Chen CS; Chuang CK; Weng HH; Pang ST
    J Urol; 2006 Aug; 176(2):477-81. PubMed ID: 16813872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma.
    Akdogan B; Dogan HS; Eskicorapci SY; Sahin A; Erkan I; Ozen H
    J Urol; 2006 Jul; 176(1):48-52. PubMed ID: 16753365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.
    Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Segura JW; Zincke H; Elliott DS; Blute ML
    J Urol; 2007 May; 177(5):1721-6. PubMed ID: 17437796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of endoscopically treated upper urinary tract transitional cell carcinoma.
    Elliott DS; Blute ML; Patterson DE; Bergstralh EJ; Segura JW
    Urology; 1996 Jun; 47(6):819-25. PubMed ID: 8677570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
    Xylinas E; Rink M; Cha EK; Clozel T; Lee RK; Fajkovic H; Comploj E; Novara G; Margulis V; Raman JD; Lotan Y; Kassouf W; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Zigeuner R; Pycha A; Scherr DS; Seitz C; Walton T; Trinh QD; Karakiewicz PI; Matin S; Montorsi F; Zerbib M; Shariat SF;
    Eur Urol; 2014 Jan; 65(1):210-7. PubMed ID: 22579047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 71.